Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $9.74 USD
Change Today +0.27 / 2.85%
Volume 13.0K
CGIX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 3:56 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Elizabeth Adkins Czerepak

AgeTotal Calculated CompensationThis person is connected to 15 board members in 2 different organizations across 14 different industries.

See Board Relationships
59--
As of Fiscal Year 2014

Background*

Ms. Elizabeth Adkins Czerepak has been Chief Financial Officer of Vaxin Inc. since April 2015. Ms. Czerepak served as the Chief Financial Officer and Chief Business Officer of Isarna Holding GmbH from April 2014 to 2015. Ms. Czerepak was the General Partner of the funds comprising the Bear Stearns Health Innoventures Group, since April 2001. She served as the Chief Financial Officer at Cancer Genetics, Inc. from January 24, 2011 to March 31, 2014 and also served as its ...

Read Full Background

Corporate Headquarters*

201 Route 17 North
Rutherford, New Jersey 07070

United States

Phone: 201-528-9200
Fax: 201-528-9201

Board Members Memberships*

Director
Director

Education*

MBA
Rutgers, The State University of New Jersey
BA
Marshall University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CGIX:US $9.74 USD +0.27

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CANCER GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.